Global Peptide Therapeutics Market & Pipeline Insight
Bharatbook.com announces a new report on "Global Peptide Therapeutics Market & Pipeline Insight" which very significant role in modulating cell functions, peptides are used in many physiological and pathological processes.
Previously peptide drugs were not very popular. However, in recent years, as the total number of small molecule-based drugs in the clinical trials and approved drugs for the market is decreasing rapidly, the pharma companies along with the academia are increasingly paying more attention to peptides or other bioactive drugs. At present, in the global market, there are close to 90 approved peptide drugs, with 278 more in clinical trials and 319 additional ones in the pre-clinical studies.
There are many applications of the peptide drugs. The most popular and dominant segments include cancer peptide segment, which accounted for the largest share of more than 20%. It is most likely that due to rising incidence of cancer across the globe, this application market is expected to record a strong growth in the future. The second significant segment of peptide drugs is the neuropeptides application segment, which is expected to record a growth rate of more than 9-10% through 2018 owing to an increasing number of neurological disorders such as Alzheimer's and Parkinson's disease across the globe.
With significant advancements in genomics which have identified new targets for peptide drugs and a rising popularity and awareness among the patients about the better safety levels than small molecule drugs, the global market for peptide therapeutics was estimated to be close to USD 17 billion in 2013. With factors such as rising incidence of cardiovascular diseases, metabolic diseases and advances in technology actively pushing the demand for peptide drugs, this market is expected to grow at a CAGR of 9-10% to reach approximately USD 27.3 billion by 2018.
“Global Peptide Therapeutics Market & Pipeline Insight” Report Highlights & Key Findings:
• Global Peptides Drug Market Overview
• Peptides Pipeline by Phase, Indication & Country
• Peptide Pipeline by Peptide Class
• Competitive Landscape
• Peptides in Development Phase: 597
• Marketed Peptides: 90
• Maximum Number of Peptides in Preclinical Phase: 253
• Maximum Number of Peptides Belongs To: Peptides/ Peptide Hormones/ Peptide Fragments
Table of contents :
1. Global Peptide Market Outlook (http://www.bharatbook.com/
1.1 Introduction to Peptides
1.2 Market Overview
1.3 Regional Market Analysis
1.4 Market Drivers
1.5 Issues to be Addressed
1.6 Peptide Clinical Pipeline Analysis
2. Peptides/ Peptide Hormones/ Peptide Fragments Pipeline by Phase, Indication & Country
2.1 Research till Preregistration
3. Cyclic Peptides Pipeline by Phase, Indication & Country
3.1 Research till Preregistration
4. Depsi Peptides Pipeline by Phase, Indication & Country
4.1 Research till Preregistration
5. Dipeptides Pipeline by Phase, Indication & Country
5.1 Research till Preregistration
6. Glyco Peptides Pipeline by Phase, Indication & Country
6.1 Research till Preregistration
For more information kindly visit : http://www.bharatbook.com/
Related link : http://www.bharatbook.com/
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: https://
Follow us on linked in : http://www.linkedin.com/
Our Blog : http://blog.bharatbook.com/
Bharat Book Bureau
+91 22 27810772